Invicta Diagnostic Ltd. IPO Details – Price, Date, GMP & Analysis
Invicta Diagnostic Ltd. IPO Overview
Company Overview
Invicta Diagnostic Limited, incorporated in January 2021, offers radiology and pathology solutions under the brand 'PC Diagnostics' through 7 diagnostic centers and a central laboratory in Mumbai. The company specializes in integrated pathology and radiology services, providing around 60 routine and 487 specialized pathology tests, along with 96 basic and 130 advanced radiology tests. As of May 31, 2025, Invicta Diagnostics has a network of 5 laboratory doctors, 20 radiologists, and 127 technical staff, employing a total of 105 permanent employees.
IPO Timeline
Timeline information will be updated when available.
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 3.51x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 6.96x | Oversubscribed |
| RII (Retail Individual Investors) | 3.44x | Oversubscribed |
| Total Subscription | 4.27x | Oversubscribed |
Last updated: Dec 3, 2025, 06:21 PM
Financial Information
Financial information will be available when the company releases its DRHP.
Strengths & Risks Analysis
Key Risks
Potential challenges and risk factors
- Business heavily depends on promoters’ expertise and continued involvement.
- High capital expenditure and equipment maintenance may impact profitability.
- Industry faces intense competition from established diagnostic chains.
- Regulatory changes in healthcare and diagnostics may affect operations.
- Revenue concentration in limited geographical regions increases business risk.
IPO Details
Detailed information will be available closer to the IPO launch date.
Key Dates
